In breast cancer, α-ketoglutarate activates collagen hydroxylation by increasing collagen prolyl-4-hydroxylase (P4HA) activity, which impairs the growth of breast cancer-derived lung metastases [38]. This evidence concerns the gene P4HA1 and breast cancer.